Ads
related to: dcis recurrence rate after mastectomy
Search results
Results From The WOW.Com Content Network
Some institutions that have encountered high rates of recurrent invasive cancers after mastectomy for DCIS have endorsed routine sentinel node biopsy (SNB). [39] However, research indicates that sentinel node biopsy has risks that outweigh the benefits for most women with DCIS. [40]
Invasive carcinoma NST is one of the most common types of all breast cancers, accounting for 55% of breast cancer incidence. [2] Of the invasive breast cancers, invasive carcinoma NST accounts for up to 75% of cases. [3] [4] It is also the most common form of breast cancer occurring in men, accounting for 85% of cases. [5] [6]
Comedocarcinoma is a kind of breast cancer that demonstrates comedonecrosis, which is the central necrosis [1] of cancer cells within involved ducts. Comedocarcinomas are usually non-infiltrating and intraductal tumors, characterized as a comedo-type, high-grade ductal carcinoma in situ (DCIS).
DCIS is usually treated with breast-conserving surgery or a mastectomy, Harb says. The decision to do so typically depends on the size of the DCIS and where it’s located.
In a follow-up 8 to 104 months (mean: 47 months) after diagnoses of 29 cases, 5 developed recurrent disease 1.5 to 7 (mean: 3.3) years after diagnosis and 2 developed metastases, 1 to lung and 1 to bone. By the end of the study, 47 individuals had no evidence of disease and 2 had died of unknown causes.
The rate of cancer recurrence is determined by many factors, including age, sex, cancer type, treatment duration, stage of advancement, grade of original tumor, and cancer-specific risk factors. [2] [3] [4] If recurrent cancer has already moved to other body parts or has developed chemo-resistance then it may be more aggressive than original ...
Ads
related to: dcis recurrence rate after mastectomy